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Abstract - Crystallization is an important industrial-scale process for the purification of enantiomers 
that depends on a phase diagram. In this work, the ternary phase diagram of R- and S-ketamine in 
ethanol was determined. The eutectic point indicated that crystallization of pure enantiomers from 
solutions containing more than 75% of the desired enantiomer is feasible. Solubility studies showed the 
feasibility of using temperature control to conduct the process. Batch crystallization of ketamine 
(S/R:80/20) solutions at 25°C provided the isolation of S-ketamine (purity of 100%) with a yield from 
65 to 70% and a productivity of 6.5 g/(l h). 







(Figure 1), known by its generic name ketamine, is a 
drug with sedative, analgesic and anesthetic properties, 
whose molecular structure has a chiral center thus 
having two enantiomers: S- and R-ketamine. Since its 
introduction on the market, several studies have 
recommended its use for post-operatory anesthesia and 
analgesia, thereby minimizing the use of opiates, which 
induce very often hyperalgesia (Luft and Mendes, 
2005). The problems associated to this drug when 
used in the same doses as those used in common 
anesthesia are the adverse effects, such as 
undesirable psycho reactions and illusions, caused by 
the R-enantiomer (Nishizawa et al., 2000). A feasible 
alternative to avoid these problems is the use of an 
optically pure drug containing only the S-enantiomer 
instead of the commonly used racemic form. 
Commercialization of pure enantiomers, however, 
depends on the availability of an industrially 
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(S): anesthetic (R): hallucinogen
 
Figure 1: Molecular structure of ketamine with a representation of its stereoisomerism. 
 
 
Studies in the literature regarding the 
enantioseparation of ketamine have been mostly 
related to chiral chromatography (Silva et al., 2005a; 
Silva et al., 2005b; Santos et al., 2004) and 
diastereomeric resolution (Steiner et al., 2000; Russo 
and Russo, 2003). In the chromatographic processes 
microcrystalline cellulose triacetate (MCTA) has 
been used as the chiral stationary phase, achieving 
purifications of virtually 100%. These processes 
have been carried out in HPLC (Silva et al., 2005a; 
Silva et al., 2005b) and in simulated moving bed  
(SMB) units (Santos et al., 2004).. A limitation of 
these processes has been their low productivity (0.15 
to 0.5 gram per day), even when using the SMB 
technology in a laboratory-scale unit. A decay in 
productivity as the level of purification increases is 
usually observed in chromatographic processes.  
In the diastereomeric resolution processes, 
separation of S-ketamine is based on the application 
of L-(+)-tartaric acid as the resolution agent, 
allowing the selective crystallization of S-ketamine 
tartrate salt (Steiner et al., 2000; Russo e Russo, 
2003). Diastereomeric resolution is one of the most 
traditional techniques in the enantioseparation field. 
However, compared to direct crystallization, it has 
the disadvantage of requiring additional steps for salt 
conversion, thereby increasing the overall processing 
time (Wang et al., 2004). To our knowledge, there is 
no study in the literature related to the direct 
crystallization or even the solubility of rac-ketamine 
or its enantiomers.  
In this study, we determined the ternary phase 
diagram of R- and S-ketamine in ethanol and the 
primary conditions for the crystallization of S-
ketamine as well as the feasibility of applying it as 
the predominant or as an auxiliary process. 
 
ENANTIOSEPARATION  VIA CHROMATOGRAPHY 
AND CRYSTALLIZATION 
 
In the past two decades, remarkable progress has 
been achieved in the field of enantioseparation, with 
a significant contribution of chiral chromatography, 
carried out in preparative HPLC or in simulated 
moving bed (SMB) units for large-scale production.  
The SMB technology was a breakthrough in 
increasing the productivity of chromatographic 
separations; however, a significative decrease in 
productivity can still be observed as the level of 
purification increases. For this reason, some authors 
have been pursuing the use of hybrid processes, 
combining SMB chromatography and crystallization 
in order to obtain an increase in productivity (Lim et 
al., 1995; Lorenz et al, 2001; Bléhaut et al., 2001; 
Gedicke, 2005; Lorenz et al., 2006). The general 
concept of the hybrid process is based on using 
chromatography as a prepurification stage, followed 
by a crystallization step to achieve the final 
purification. The advantage is that it overcomes the 
problem of low productivity found in the former 
process, while meeting the usual requirement of 
prepurified solution in the second process.   
Crystallization is a less labor and cost demanding 
process than chromatography; however, in only a 
few cases (5 to 10%) can it be carried out directly in 
a racemic solution. In most cases it requires an 
enriched solution with a molar excess of the desired 
enantiomer, which makes coupling it with 
chromatography a very attractive alternative. The 
design and optimization of the hybrid 
chromatography-crystallization process is discussed 
in Fung and Ng (2005), Ströhlein et al. (2003), and 
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(a) (b) 
Figure 2: Illustration of typical ternary phase diagrams involving enantiomeric systems: a−phase diagram 
of a conglomerate forming system; b−phase diagram of a racemic compound-forming system. 
 
 
The feasibility of crystallization as the 
predominant or the auxiliary process depends on the 
shape of the ternary phase diagram of the 
enantiomers in a suitable solvent. When the crystal-
forming system characterizes a conglomerate 
(physical mixture of crystals of the pure 
enantiomers), the diagram (Figure 2a) has one 
eutectic point (E) which is exactly at the 50:50 
composition and crystals of pure S and R 
enantiomers are obtained respectively in the SAE 
and REA’ regions of the diagram. On the other 
hand, when the crystal-forming system 
characterizes a racemic compound (crystals with 
equal amounts of the two enantiomers in the 
crystalline unit), the diagram (Figure 2b) has two 
eutectic points (E and E’) and crystals of pure 
enantiomers are obtained in the regions SAE and 
RE’A’. Provided that a certain rac-mixture is of the 
conglomerate type, a straightforward strategy to 
isolate only one of the enantiomers is to add small 
crystals of the desired enantiomer to the 
supersaturated racemic solution, which causes the 
preferential crystallization of the specie added. On 
the other hand, provided that the mixture is of the 
compound type, a previous enrichment that 
produces a purification level above the eutectic 
composition is required in order to make 
crystallization a suitable process. About 90 to 95% 
of chiral organic molecules are racemic compounds 
and only 5 to 10% are conglomerates (Jacques et 
al., 1981; Profir et al., 2002). Therefore, the direct 
crystallization of enantiomers without a 
prepurification step is strongly limited and its 
coupling with an other process, such as 






Ketamine racemate and enantiomers with purities 
above 98% were kindly supplied by Cristália 
Produtos Químicos Farmacêuticos (Itapira, SP, 
Brazil) in their base and hydrochloride forms. A 
conversion procedure was implemented in order to 
convert the hydrochlorides into their base forms. 
Solvents used for the solubility studies and 
chromatographic analysis were of analytical and 
HPLC grades, respectively. 
 
Ketamine Hydrochloride Conversion 
 
1.0 M sodium bicarbonate solution was slowly 
added to the aqueous ketamine hydrochloride 
solution under stirring until the solution pH was 
close to 11. Stirring was continued for 16 h, and then 
the base form of ketamine was extracted with 
dichloromethane. The solvent was eliminated by 
evaporation in a rotatory evaporator and an HPLC 
analysis was performed in order to confirm the purity 
of the converted product.   
 
X-Ray Powder Diffraction (XRPD) 
 
XRPD measurements were carried out using X 
PERT PRO MRD Philips equipment (USA) with Cu-
Kα radiation. The Bragg-Brentano geometry with a 
diffracted beam pirolytic graphite monochromator 
was used and the scans were taken with 40 kV - 40 
mA in the 10 - 50 deg (2θ) range with a step size of 
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The solid ATR-FTIR spectra of ketamine 
racemate and enantiomers were collected in a 
Bomem-Hartmann & Braun IR spectrophotometer 
(USA). KBr pellets were properly prepared to 
contain approximately 1 wt% of each compound and 
sampled from the average of 150 scans using a 




Solubility was determined in a temperature range 
of 5 to 40ºC in small vials containing about 1.0 ml of 
the ketamine/ethanol suspensions. The amount of 
total solute in the suspensions varied from 50 to 230 
mg/ml. Temperature control and stirring were 
provided by a thermostatic bath and a bench shaking 
table. After the equilibrium time (previously 
determined through kinetic experiments), the 
suspensions were centrifuged at 2000g for 2 min in a 
thermostatically controlled centrifuge (Nova 
Técnica, Brazil). The liquid phase was then filtered 
with 0.45 μm Millex membranes (Millipore, USA) 
and analyzed for ketamine concentration, based on 
the absorbance at 245 nm in a UV-VIS 
spectrophotometer (Beckman, USA). Equilibrium 
time was determined at 5 and 25ºC for each of the 
enantiomers and for the racemate by dissolution 
assays with periodical measurement of the liquid 
phase concentration until no change was observed.  
In order to determine the ternary phase diagram 
(at 25ºC), solubility measurements were carried out 
(in duplicate) for suspensions with different ratios of 
R- and S-ketamine, all of which had a total of 300 
mg/ml of solute. After equilibrium was reached, 
concentration of the liquid phases was measured 
with a UV-VIS spectrometer and both liquid and 
solid phases were analyzed with regard to the 
enantiomeric composition in HPLC equipment 




Batch crystallization was carried out in volumes 
of 20 to 30 ml of R/S-ketamine/ethanol suspensions 
containing an enantiomeric excess of 80% of the S-
enantiomer. The solute/solvent ratio varied from 150 
to 250 mg/ml and the processing time from 4 to 20 h.  
Suspensions were initially heated (45ºC for 1 h) for a 
complete dissolution of the solids and then cooled to 
a temperature of 25ºC at a cooling rate of 
0.67ºC/min. The clear solutions were then stirred at a 
constant temperature (25ºC) during the established 
processing times. At the end of the process, the 
liquid phases were filtered through 0.45 μm 
membranes and analyzed with HPLC. The solid 
phases were left in an oven for 30 min with air 
circulation at 35ºC, and the resulting crystals were 
redissolved and evaluated with HPLC with regard to 
S-ketamine purity.   
 
 




Characterization of ketamine samples was done 
by infrared spectroscopy and XRPD in order to 
identify the racemate crystal-forming system as 
belonging to one of the two main classes: 
conglomerate or racemic compound. In both of these 
methods, the opposite enantiomers always provide 
identical results, enantiomers and respective 
conglomerate provide identical results and 
enantiomer and respective compound provide 
different results (Jacques et al., 1981). Therefore, 
differences in the infrared spectra or in the XRPD 
patterns of the racemate and the enantiomers are an 
indication that the product is a racemic compound.  
The infrared spectra of S-ketamine and rac-
ketamine (Figure 3) showed similar peaks for the 
vibrations of the main chemical bonds, including the 
aliphatic C-H vibration in the 3000-2850 cm-1 range, 
the aromatic hydrogen vibrations around 3000 cm-1, 
the methyl group at 2800 cm-1 and the carbonyl 
groups at 1700 cm-1. However, different vibrations 
are observed mainly around 2900 cm-1 within the 
aliphatic group’s range, around 3400 cm-1 for N-H 
bonds, and within the 700-800 cm-1 range for the C-
Cl bonds. The different vibrations observed in the 
two spectra suggest that ketamine racemate is 
certainly a racemic compound. 
The PXRD patterns (Figure 4) confirm the 
hypothesis that the product is a racemic compound.  
The diffraction patterns of the enantiomer and the 
racemate are remarkably different from each other.     
 
Solubility Studies and the Ternary Phase 
Diagram 
 
Solubilization assays conducted at 5 and 25ºC 
indicated that a time interval of 10 h was enough for the 
ketamine/ethanol suspensions to reach equilibrium 
(data not shown). For the racemic mixture at 5ºC, 
dissolution up to 100 mg/ml was observed within the 
first hour of solubilization, before effectively reaching 
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hours. A possible explanation of this is the occurrence 
of a metaestable conglomerate in the initial stage, 
which assumed the compound form at equilibrium. A 
similar fact was observed in Profir et al. (2002) where 
the authors reported a possible metaestable 
conglomerate in the initial hours of the crystallization 
of mandelic acid in water, known to appear as a 
racemic compound. Polymorphism is a critical issue in 
the crystallization process, and therefore, further 
investigation should be performed to elucidate the fact.   
The solid-liquid equilibrium curves for the ketamine 
isomers and racemate were then determined in a 
temperature range of 5 to 40ºC (Figure 5). The 
solubility of the enantiomers as well as of the racemate 
increased with increasing temperature. The solubility of 
the racemate was higher than those of the pure isomers, 
which as expected, had identical solubilities. The 
solubility curves indicated a reasonable influence of 
temperature, implying that the crystallization of 




Figure 3: Infrared spectra of racemic ketamine (a) and S-ketamine (b) obtained with the KBr method. 
 
Figure 4: X-ray diffraction patterns of rac-ketamine (a) and S-ketamine (b), using Cu-Kα radiation at a 
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Figure 5:  Solubility of racemic ketamine ( ), S-ketamine ( ) and R-ketamine ( ) in ethanol.  
Average of four repetitions with a standard deviation of 0.007 wt%. 
 
 
Figure 6:  Ternary phase diagram of S/R ketamine in ethanol at a temperature of 25ºC. 
 
 
The ternary phase diagram was determined 
(Figure 6), based on the measurement of the 
solubility of solutions containing different molar 
fractions of each enantiomer. Only one side of the 
diagram was determined, given that it is symmetrical 
when related to stereoisomers. Determination of only 
one side of the diagram is very common, avoiding 
unnecessary work and reducing the number of 
assays. The fact that the diagram was determined on 
R-ketamine and not on the S- form, which is the 
desired isomer, was due to the higher availability of 
the R-enantiomer. 
The ternary phase diagram had a eutectic point at 
the enantiomeric composition of 75/25: R/S, 
indicating that the crystallization of ketamine in the 
presence of ethanol provides a racemic compound. 
According to these results, the enantioselective 
crystallization of ketamine from solutions containing 





Batch crystallizations were conducted at 
different supersaturations (150 and 250 mg/ml) 
and processing times (4 and 20 h). The highest 
productivity under the specified conditions was 
6.5 g/(l h), obtained from a suspension of 150 
mg/ml stirred for 4h. A purity of 100% and yields 
of 65 to 70% were observed independent of the 
supersaturation and the processing times. A 
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combination of the highest supersaturation (250 
mg/ml) and the shortest processing time (4h) could 
possibly provide a productivity of 24 g/(l h). Since 
these assays consisted in preliminary trials, only 
possible yields and productivities were estimated 
and an optimum condition was not determined. 
The conditions applied were chosen arbitrarily and 
certainly an optimization of the enantioselective 
crystallization of S-ketamine as well as the 
feasibility of its coupling with chromatography 
depends on more detailed studies. Nonetheless, 
these preliminary results demonstrated the 
potential of coupling crystallization with 
chromatography as a mean for increasing the 
productivity. A parallel analysis with the 
productivity of 0.5 g/(l h) reported by Santos et al. 
(2004) for the chromatographic separation of S-
ketamine indicates that the coupling of these two 
processes is a very attractive alternative for the 
resolution of S-ketamine. 
In a possible coupling of crystallization with 
chromatography, the productivity of the overall 
process must take into account other aspects, such as 
the time required for the concentration step. Usually 
the solution obtained by chromatography is diluted, 
and a crystallizer requires supersaturated solutions.  
In the particular case of ketamine, the final 
concentration of S-enantiomer obtained in a typical 
SMB chromatographic unit (Santos et al., 2004) was 
5 mg/ml, which is 30 to 50 times lower than the 
concentration used in the crystallization assays in the 





The present study has demonstrated the potential 
of applying crystallization for the enantioselective 
separation of ketamine. According to the ternary 
phase diagram using an enriched solution with an 
enantiomeric excess above 75% was required to 
crystallize the pure stereoisomer. This made the 
process more suitable as an auxiliary process, 
designated to complement a previous chromatographic 
separation step. Chromatographic purification only 
up to 75% would reduce the number of cycles 
significantly more than full purification, thus 
increasing productivity. A purity of virtually 100% 
and yields from 65 to 70% were found for 
preliminary batch crystallizations regardless of 
processing time and supersaturation. A combination 
of the best conditions studied allowed the 
projection of a possible productivity of 24 g/(l h).  
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